Navigation Links
Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting
Date:10/29/2009

discontinuation rates for disturbance in attention that were at least three times greater than what was observed in our studies. These results were consistent with the expected profile and previous experience of Qnexa in our studies," stated Leland Wilson, president and chief executive officer of VIVUS. "We believe this additional data further substantiates the safety profile of Qnexa. Taken in the context of the statistically significant weight loss and improvement on co-morbidities, Qnexa has a positive benefit/risk profile. Completion rates for patients on Qnexa were significantly better as compared to placebo in the phase 3 trials. We believe the overall efficacy and safety profile of Qnexa supports approvability."

The company anticipates filing the NDA for Qnexa by the end of 2009.

Previously reported highlights from the EQUIP and CONQUER studies were included in the presentation:

  • Average weight loss of 14.7% (37 lbs) was achieved by patients treated with Qnexa for 56 weeks in the EQUIP study;
  • Significant improvements in cardiovascular, metabolic and inflammatory risk factors among patients treated with Qnexa;
  • FDA efficacy benchmarks for weight loss agents were exceeded at all three doses of Qnexa tested in the clinical program; and
  • Completion rates up to 69% were significantly higher than placebo at all three doses of Qnexa, indicating favorable tolerability.
  • Across both 56-week studies, the most commonly reported side effects were dry mouth, tingling, constipation, altered taste and insomnia.
  • There were no serious adverse events reported for cognitive disorders.

EQUIP (OB-302) Study Overview

The EQUIP study included 1,267 morbidly obese patients (1,050 females and 217 males) across 93 centers in the United States. The average baseline BMI of the study population was 42.1 kg/m(2) and baseline weight was 256 pounds. Patients had
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
3. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
4. PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
5. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
6. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
7. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
8. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
9. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
10. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
11. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 ... Monitoring & Cardiac Rhythm Management Market ECG, Implantable ... Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, ... MarketsandMarkets, the global Cardiac Monitoring (CM) and Cardiac ... reach $26,646.5 Million by 2020 from $21,137.7 Million ...
(Date:7/3/2015)... , July 3, 2015 A ... of hypertension, diabetes and thyroid disorders in ... and a major conference dedicated to these diseases. ... Diabetes Online , Manage Hypertension Online and ... operated by EXCEMED - combine the world,s ...
(Date:7/3/2015)... , July 3, 2015  Obsidian HDS, the ... an online service for the management of data on ... today that PharmaShine now includes the 2014 Open Payments ... Medicare Services on June 30. The data disclosed on ... transactions between industry and providers totaling $6.49 billion and ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... BRUSSELS, August 31, 2011 Research into blood-related ... citizens each year, but lack of awareness of this fact ... into advancing the treatment of patients. "Haematology is ... in recent years," said Professor Robin Foà of "La Sapienza" ...
... RIVER, Mass., Aug. 31, 2011 Millstone Medical ... Neuberger as Vice President of Operations of the ... manufacturing executive, will have overall responsibility for managing ... kit processing and distribution, a core function of ...
Cached Medicine Technology:Better Funding for Research into Blood Diseases Will Save More Lives 2Millstone Medical Outsourcing Hires Seasoned VP of Operations to Run Memphis Facility 2
(Date:7/5/2015)... ... July 05, 2015 , ... ... the Weed Master, a landscaping invention that effectively removes weeds without harming ... dollars," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "It ...
(Date:7/4/2015)... ... July 04, 2015 , ... Earlier in ... results of an annual member survey , detailing the most common plastic surgery ... group broke that raw data down into charts detailing demographic trends and regional ...
(Date:7/3/2015)... ... ... will hopefully be getting a large donation of canned food items at the end ... making it their mission to collect as many canned items as possible. Donations do not ... as well. As part of the canned food drive, these local chiropractors will be donating ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers ... minimal asbestos exposure. Click here to read the complete story , just posted ... Center, Cedars Sinai Medical Center, and New York University exposed mice with a mutation ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar ... at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar ... points of investigating these types of cases. , Each year, New York State ...
Breaking Medicine News(10 mins):Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2
... University have successfully produced Plague vaccines from Tobacco plants. ... // plant which is found to be effective against ... The researchers are to start a clinical trial of ... of the new vaccine. The researchers have reported the ...
... undergo a lot of mental strain contracting heart diseases, according ... in blood pressure and brain activity during stress. ... its links to stress and heart disease has been taken ... used functional magnetic resonance imaging (FMRI), a non-invasive technique for ...
... patients who need psychiatric care in the UK are being ... to a massive shortage // of NHS beds. ... crisis management, with patients being sent home at night or ... from the Mental Health Act Commission. ,The team ...
... A research was conducted by Lijing l. Yan, PhD., M.P.H., ... Peking University, China, and colleagues on the effects of overweigh ... // ,The Chicago Heart Association study conducted a ... studied from 31 year of age through 64 years. They ...
... Australian rural doctors who specialize in surgery, obstetrics and ... federal Government just to continue the work they are ... incentives to push general practitioners who carry out procedures ... that will cost taxpayers an extra $5.2million each year. ...
... virus’ signature has not been seen in India so far, ... N.Ganguly // . The institution has also set up with ... are also being kept under surveillance to ensure that the ... ,The normal flu vaccine is also sought to be enhanced, ...
Cached Medicine News:Health News:Tobacco plant based Vaccine against Plague 2Health News:NHS faces mental health crisis; 'risky' patients sent home 2Health News:Obesity Increases The Risk Of Cardiovascular Diseases 2Health News:Specialist rural GPs to get incentive in Australia 2
... The biokitHSV-2 Rapid Test is a single ... in heparinized capillary whole blood taken by ... specific for herpes simplex virus type 2 ... with HSV-2. It is intended for in-vitro ...
... Piccolo is the first compact, broad menu ... testing in any treatment setting. Care givers ... panels with less than one minute of ... comparable in quality to larger, expensive laboratory ...
The GelPort XE hand access system combines the technology of the GelSeal® cap with the retraction and protection of the Alexis wound retractor....
The CPAP TREND 110 delivers performance with quiet operation. Can be used together with the SomnoPlus CPAP Mask and AquaTrend Heated Humidifier....
Medicine Products: